Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03972787 · ClinicalTrials.gov registry record · NA
Effects of a Proactive Social Robot for Older Adults in Reducing Loneliness and Social Isolation
A NA study of Quality of Life and Loneliness, sponsored by Baycrest.
- Completed
- Registry status
- NA
- Development phase
- 54
- Enrollment target
- 2
- Study locations
NCT03972787: Completed NA study of Quality of Life and Loneliness, sponsored by Baycrest.
NCT03972787 is a NA study of Quality of Life and Loneliness that has completed, run by Baycrest. The registered enrollment target is 54 participants, below the 452-participant average among 107 other Quality of Life trials with a reported enrollment target (88% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03972787, a NA study of Quality of Life and Loneliness, has completed, sponsored by Baycrest.
- COMPLETED
- Registry status
- NA
- Development phase
- 54 participants
- Enrollment target
- 2
- Study locations
Study Summary
This project will to evaluate whether a proactive social robot (ElliQ) has an impact on reducing social isolation and loneliness in older adults who are living alone, while also promoting independence and aging in place. To achieve this, the following research questions will be investigated: 1. How does the use of ElliQ impact the following outcomes in older adults: * Loneliness and social isolation; * Accessibility to and use of technology; * Quality of life, mood, and overall well-being; and * Caregiver experience? 2. Do particular characteristics of the older adult population influence these impacts?
Primary Outcome
The UCLA Loneliness V3 scale is a 20-item scale measuring loneliness and social isolation; it has been validated in older adult populations. For this scale, 11 items are worded negatively to indicate loneliness, while 9 are worded positively (and are reverse scored) to indicate social connectedness. Participants are asked to rate their responses on a 4-point scale, with responses ranging from 1 ("never") to 4 ("often"). The individual items are then tallied and a total score is calculated (range
Conditions Studied
Interventions
- DEVICE Proactive social robot
Study Locations (2)
California
- Jewish Senior Living Group - San Francisco
Ontario
- Baycrest - Toronto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2019-03-05 |
| Est. Completion | 2020-07-31 |
| Phase | NA |
What the finished NCT03972787 record still lists
NCT03972787 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 54 participants, a relatively small participant target, below the 452-participant average among 107 other Quality of Life trials with a reported enrollment target (88% lower).
The record links to 3 conditions, with Quality of Life appearing as the primary indexed condition, and to 1 intervention - of which Proactive social robot is the first listed.
NCT03972787 reports a single indexed study location in California, Ontario.
Frequently Asked Questions
What is clinical trial NCT03972787 about?
NCT03972787 is a clinical study titled "Effects of a Proactive Social Robot for Older Adults in Reducing Loneliness and Social Isolation". This project will to evaluate whether a proactive social robot (ElliQ) has an impact on reducing social isolation and loneliness in older adults who are living alone, while also promoting independence and aging in place. To achieve this, the following research questions will be investigated: 1. How...
What is the current status of trial NCT03972787?
This trial is currently completed. It is a NA study. The enrollment target is 54 participants. The study started on 2019-03-05. Estimated completion is 2020-07-31.
What conditions does trial NCT03972787 study?
This clinical trial studies the following conditions: Quality of Life, Loneliness, Mood.
What interventions are being tested in trial NCT03972787?
The interventions under investigation include: Proactive social robot (DEVICE).
Who is sponsoring clinical trial NCT03972787?
This trial is sponsored by Baycrest, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03972787 being conducted?
This trial has 2 study locations across California, Ontario. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Quality of Life
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03972787's enrollment target sits among peer trials
54 67th of 107 higher than 40 of 107 other Quality of Life trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Quality of Life trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)
RECRUITING · NA
-
Development of a Multi-sensory Rehabilitation Program for People With Ultra Low Vision
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Therapeutic Plantar Electrical Stimulation Intervention During Hemodialysis to Improve Balance and Mobility
RECRUITING · NA
-
Trajectories of Recovery After Intravenous Propofol Versus Inhaled VolatilE Anesthesia Trial
RECRUITING · NA
-
Asthma Intervention With Residential Ventilation and Air Cleaner (AIRVAC) Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01269853 · 54 participants · Phase 1
Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA
- NCT02390752 · 54 participants · Phase 1
Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
- NCT02991248 · 54 participants · NA
Improve Dynamic Lateral Balance of Humans With SCI
- NCT02993900 · 54 participants · NA
Image-Guided Gynecologic Brachytherapy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI